Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mager

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Pulmonary Circulation|August 23, 2024
Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapiesDiederik P Staal, Paul M Hendriks, Mitch C J van Thor, et al.
Orphanet Journal of Rare Diseases|August 30, 2019
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasiaC L Shovlin, C M Millar, F Droege, et al.
Chest|May 13, 2026
Pretreatment with mono or dual PH-targeted medical therapy in patients undergoing balloon pulmonary angioplasty: effect on complications and clinical outcomesD P Staal, R Y Lely, A Breuning, et al.
Circulation|November 8, 2006
Endoglin has a crucial role in blood cell-mediated vascular repairLinda W van Laake, Sander van den Driesche, Simone Post, et al.
Circulation|December 21, 2018
Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2Jérémy H Thalgott, Damien Dos-Santos-Luis, Anna E Hosman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 30, 2019
Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the NetherlandsM C J van Thor, R J Lely, N J Braams, et al.
European Journal of Medical Genetics|November 5, 2021
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality careC L Shovlin, E Buscarini, C Sabbà, et al.
The Netherlands Journal of Medicine|January 8, 2014
Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the NetherlandsS M Huijts, C H van Werkhoven, W G Boersma, et al.
Journal of Medical Genetics|June 26, 2009
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasiaM E Faughnan, V A Palda, G Garcia-Tsao, et al.
Annals of Internal Medicine|September 7, 2020
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic TelangiectasiaMarie E Faughnan, Johannes J Mager, Steven W Hetts, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Pulmonary Circulation|August 23, 2024
Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapiesDiederik P Staal, Paul M Hendriks, Mitch C J van Thor, et al.
Orphanet Journal of Rare Diseases|August 30, 2019
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasiaC L Shovlin, C M Millar, F Droege, et al.
Chest|May 13, 2026
Pretreatment with mono or dual PH-targeted medical therapy in patients undergoing balloon pulmonary angioplasty: effect on complications and clinical outcomesD P Staal, R Y Lely, A Breuning, et al.
Circulation|November 8, 2006
Endoglin has a crucial role in blood cell-mediated vascular repairLinda W van Laake, Sander van den Driesche, Simone Post, et al.
Circulation|December 21, 2018
Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2Jérémy H Thalgott, Damien Dos-Santos-Luis, Anna E Hosman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 30, 2019
Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the NetherlandsM C J van Thor, R J Lely, N J Braams, et al.
European Journal of Medical Genetics|November 5, 2021
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality careC L Shovlin, E Buscarini, C Sabbà, et al.
The Netherlands Journal of Medicine|January 8, 2014
Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the NetherlandsS M Huijts, C H van Werkhoven, W G Boersma, et al.
Journal of Medical Genetics|June 26, 2009
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasiaM E Faughnan, V A Palda, G Garcia-Tsao, et al.
Annals of Internal Medicine|September 7, 2020
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic TelangiectasiaMarie E Faughnan, Johannes J Mager, Steven W Hetts, et al.
Pageof 9